UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Approach to the differential diagnosis of leg ulcers

Author
Marta J Petersen, MD
Section Editor
Erik Stratman, MD
Deputy Editor
Abena O Ofori, MD

INTRODUCTION

Leg ulcers are an increasing problem worldwide and represent a major healthcare burden. Patients with leg ulcers are managed by clinicians in multiple specialties, including primary care, vascular surgery, plastic surgery, podiatry, wound care, and dermatology.

A leg ulcer is a physical finding that can result from multiple etiologies, rather than a diagnosis (table 1). Thus, determination of the cause is essential for selecting appropriate treatment and determining the need for further evaluation. The most common causes of leg ulcers are venous insufficiency, arterial insufficiency, and neuropathic disease (table 2).

The etiologies and approach to the differential diagnosis of leg ulcers will be reviewed here. Specific etiologies of leg ulcers and wound management are reviewed in detail separately.

(See "Overview and management of lower extremity chronic venous disease".)

(See "Clinical features and diagnosis of lower extremity peripheral artery disease".)

                          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Jul 25 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Körber A, Klode J, Al-Benna S, et al. Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey. J Dtsch Dermatol Ges 2011; 9:116.
  2. Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ 2006; 332:347.
  3. Kirsner RS, Vivas AC. Lower-extremity ulcers: diagnosis and management. Br J Dermatol 2015; 173:379.
  4. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9:71.
  5. Alavi A, Hafner J, Dutz JP, et al. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol 2013; 69:1033.
  6. Di Giacomo TB, Hussein TP, Souza DG, Criado PR. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study. J Eur Acad Dermatol Venereol 2010; 24:1340.
  7. Piazza G, Creager MA. Thromboangiitis obliterans. Circulation 2010; 121:1858.
  8. Piette WW. Cutaneous manifestations of microvascular occlusion syndromes. In: Dermatology, 3rd ed, Bolognia J, Jorizzo J, Schaffer J (Eds), Elsevier Saunders, Philadelphia; London 2012. Vol 1, p.369.
  9. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122:1194.
  10. Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007; 56:569.
  11. Mochel MC, Arakaki RY, Wang G, et al. Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol 2013; 35:582.
  12. Minniti CP, Eckman J, Sebastiani P, et al. Leg ulcers in sickle cell disease. Am J Hematol 2010; 85:831.
  13. Martí-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev 2014; :CD008394.
  14. Minniti CP, Delaney KM, Gorbach AM, et al. Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia. Am J Hematol 2014; 89:1.
  15. Moschella SL, Davis MD. Neutrophilic Dermatoses. In: Dermatology, 3rd ed, Bolognia J, Jorizzo J, Schaffer J (Eds), Elsevier Saunders, Philadelphia; London 2012. Vol 1, p.423.
  16. Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000; 79:37.
  17. Valverde R, Rosales B, Ortiz-de Frutos FJ, et al. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin 2008; 26:447.
  18. Rongioletti F, Caputo V. Pancreatic panniculitis. G Ital Dermatol Venereol 2013; 148:419.
  19. Senet P, Combemale P, Debure C, et al. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study. Arch Dermatol 2012; 148:704.
  20. Thornsberry LA, LoSicco KI, English JC 3rd. The skin and hypercoagulable states. J Am Acad Dermatol 2013; 69:450.
  21. Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol 2014; 26:96.
  22. Sirieix ME, Debure C, Baudot N, et al. Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol 1999; 135:818.
  23. Juckett G. Arthropod bites. Am Fam Physician 2013; 88:841.